Nutex Health, Inc. (NUTX) - Stock Analysis
Last updated: Apr 25, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠Solid Margins ⢠Elevated Leverage NUTX looks fundamentally strong with solid profitability, strong cash generation, and moderate valuation, but elevated leverage and a weak historical equity base remain the main risks.
Price Behavior
Key Price Behavior Insights: ⢠Higher lows ⢠Support holding ⢠Near-term resistance Support Level: $100 to $101 Resistance Level: $109.00 to $109.30 NUTX has strengthened over the last month with higher lows and support above $100, but it still needs a decisive close above $109.30 to confirm a breakout.
Sentiment & News
Key News Insights: ⢠Earnings Date ⢠10-Q Filing ⢠Investor Update Nutex Health announced it will report Q1 2026 results and file its 10-Q on April 30, giving investors a near-term update on quarterly performance.
AI Summary
NUTX is no longer just a growth story; despite strong cash generation and profitability, the sharp Q4 revenue reset tied to arbitration eligibility means the stock now hinges on whether Q1 2026 can prove earnings and cash flow are durable and repeatable without disputed true-ups.
Description
Nutex Health, Inc. is a Houston-based, technology-enabled healthcare services company with two operating segments: a Hospital division that owns and operates 21 facilities across eight states, including micro-hospitals, specialty hospitals and hospital outpatient departments; and a Population Health Management division that manages provider networks and delivers management and administrative support to affiliated hospitals and physician groups. The population health unit also maintains a proprietary cloud platform that consolidates clinical and administrative data from multiple systems to provide a comprehensive view of patients and providers and to support care delivery.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 31 | Jan 7 | NUTX | Nutex Health, Inc. | Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring. | Closed | +8.2% |